Arginase inhibition slows the progression of renal failure in rats with renal ablation (Q44244709)

1 December 2017

Arginase inhibition slows the progression of renal failure in rats with renal ablation (English)

1 reference

1 December 2017

Massimo Sabbatini

1

1 reference

1 December 2017

Antonio Pisani

2

1 reference

1 December 2017

Francesco Uccello

3

1 reference

1 December 2017

Giorgio Fuiano

4

1 reference

1 December 2017

Raffaele Alfieri

5

1 reference

1 December 2017

Antonio Cesaro

6

1 reference

1 December 2017

Bruno Cianciaruso

7

1 reference

1 December 2017

Vittorio E Andreucci

8

1 reference

1 December 2017

10 December 2002

1 reference

American Journal of Physiology - Renal Physiology

1 December 2017

1 reference

1 December 2017

284

1 reference

1 December 2017

4

1 reference

1 December 2017

F680-7

1 reference

Biological effects of arginine metabolites

1 December 2017

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00270.2002

L-arginine abrogates salt-sensitive hypertension in Dahl/Rapp rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00270.2002

Expression, purification, and characterization of human type II arginase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00270.2002

Nitric oxide and angiotensin II. Glomerular and tubular interaction in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00270.2002

Supplementation with a low dose of L-arginine reduces blood pressure and endothelin-1 production in hypertensive uraemic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00270.2002

Renal hemodynamic response to maximal vasodilating stimulus in healthy older subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00270.2002

Deleterious effects of calcium channel blockade on pressure transmission and glomerular injury in rat remnant kidneys

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00270.2002

Preservation of renal function in the rat remnant kidney model of chronic renal failure by blood pressure reduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00270.2002

Angiotensin II receptor blockade limits glomerular injury in rats with reduced renal mass

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00270.2002

Agmatine, a bioactive metabolite of arginine. Production, degradation, and functional effects in the kidney of the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00270.2002

From rats to man: a perspective on dietary L-arginine supplementation in human renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00270.2002

l-Arginine supplementation increases mesangial cell injury and subsequent tissue fibrosis in experimental glomerulonephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00270.2002

Glomerular thrombosis in pregnancy: role of the L-arginine-nitric oxide pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00270.2002

L-arginine decreases the infiltration of the kidney by macrophages in obstructive nephropathy and puromycin-induced nephrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00270.2002

Dietary supplementation with L-arginine ameliorates the progression of renal disease in rats with subtotal nephrectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00270.2002

Agmatine suppresses proliferation by frameshift induction of antizyme and attenuation of cellular polyamine levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00270.2002

Agmatine affects glomerular filtration via a nitric oxide synthase-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00270.2002

Nitric oxide (NO) modulates the neurogenic control of blood pressure in rats with chronic renal failure (CRF).

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00270.2002

Immunologic studies of arginase in tissues of normal human adult and arginase-deficient patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00270.2002

Renal metabolism of amino acids and ammonia in subjects with normal renal function and in patients with chronic renal insufficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00270.2002

The renal clearance of alkali-stable inulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00270.2002

Elevated arginase I expression in rat aortic smooth muscle cells increases cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00270.2002

Arginine metabolism: nitric oxide and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00270.2002

Renal and systemic nitric oxide synthesis in rats with renal mass reduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00270.2002

Nitric Oxide Production Is Reduced in Patients With Chronic Renal Failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00270.2002

The Banff 97 working classification of renal allograft pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00270.2002

10.1152/AJPRENAL.00270.2002

21 January 2018

Identifiers

DOI

0 references

1 reference